Judge Asks GSK To Tweak Details In $10.4M Paxil Settlement
GlaxoSmithKline Inc.'s proposal to pay up to $10.4 million to resolve allegations that it misled California consumers about the risks of antidepressant Paxil will need revisions to determine how class members...To view the full article, register now.
Already a subscriber? Click here to view full article